Dual Task Performance in Rheumatic Diseases

NCT04717505 | Completed

• 1 other identifier: 2020/513
• Study Type: observational
• Target: 75
• Locations: 1 country
• Sites: 1

Brief Summary

Chronic pain is pain that exceeds the duration of the injury or trigger stimulus and lasts for at least three months. Recent studies show that chronic pain has devastating effects on cognitive functions by causing emotional stress, anxiety, and depression.The studies show that chronic pain affects certain cognitive areas. These areas are; processing speed, short-term memory, longterm memory, inhibitory control and working memory. In addition, task-oriented studies show that chronic pain affects not single tasks, but rather dual tasks that require the use of complex cognitive function (executive function). 40-60% of rheumatologic patients do not have sufficient relief in their pain. For this reason, dual task performance may be affected in individuals diagnosed with rheumatological disease, secondary to the impairment of cognition. In the literature, there are only limited studies showing dual-task performance effects in individuals diagnosed with fibromyalgia and osteoarthritis. However, chronic pain is the main health problem that prevents mobility restriction and participation in all rheumatic diseases. In addition, there is no study investigating the dual task performance effect in rheumatic diseases in a comprehensive way. Therefore, the aim of the study is to investigate the effect of rheumatic diseases on dual-task performance by comparing it with the control group.

Conditions

Rheumatic Diseases

Outcome Measures

Primary Outcomes (3)

• Gait Speed

  The time it takes to walk a specified distance

  10 minutes

• Cadence

  Number of steps per minute

  10 minutes

• Step lengths

  Step length is the distance between the point of initial contact of one foot and the point of initial contact of the opposite foot.

  10 minutes

Study Arms (2)

Healthy Control Group

Demographic information ( age, gender, occupation, weight, height) of all participants in the study will be recorded first. The cognitive functions of all participants within the scope of the study will be evaluated in the Standardized Mini Mental Test; The 10 Meter Walk Test for dual task assessments will be applied in 3 different ways, with a portable gait device with wearable sensors: 1-single task conditions, 2-dual task conditions (motor + cognitive), 3-dual task conditions (motor + motor).

Other: Gait Assessments; Other: Standardized Mini Mental Test

Rheumatological Condition Group

Demographic information (diagnosis, age, gender, occupation, weight, height) of all participants in the study will be recorded first. The cognitive functions of all participants within the scope of the study will be evaluated in the Standardized Mini Mental Test; The 10 Meter Walk Test for dual task assessments will be applied in 3 different ways, with a portable gait device with wearable sensors: 1-single task conditions, 2-dual task conditions (motor + cognitive), 3-dual task conditions (motor + motor). In addition, in order to evaluate their health status, only the case group will be applied Arthritis Impact Measurement Scales 2 (questionnaire) and Visual Analogue Scale for pain assessment.

Other: Gait Assessments; Other: Arthritis Impact Measurement Scales 2; Other: Visual Analogue Scale; Other: Standardized Mini Mental Test

Interventions

Gait Assessments OTHER

10 Meter Walking Test: It is applied by walking at a normal walking speed (like walking in a shopping mall) without any assistance at a marked distance of 10 meters. 1- Evaluation of walking under single task conditions is done with the 10 Meter Walk Test and without any cognitive or motor second task. Evaluation of walking under dual task conditions is applied in two different ways: 2-adding a cognitive task to the walking motor task (motor + cognitive dual task) 3-adding one more motor task to the walking motor task (motor + motor dual task). While performing dual tasks, the time-distance (walking speed, cadence, stride length) characteristics of the gait are recorded using with wearable gait device.

Also known as: 10 meter Walking Test

Healthy Control Group; Rheumatological Condition Group

Arthritis Impact Measurement Scales 2 OTHER

It is a multidimensional, disease-specific, self-administered questionnaire designed to measure health status outcomes in patients with arthritis.

Rheumatological Condition Group

Visual Analogue Scale OTHER

The Visual Analogue Scale is a reliable and easily applicable scale used to measure the pain intensity of patients, accepted in the world literature.

Rheumatological Condition Group

Standardized Mini Mental Test OTHER

Although the test has limited specificity in terms of differentiating clinical syndromes, it is a short, useful and standardized method that can be used to determine the cognitive level globally.

Healthy Control Group; Rheumatological Condition Group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

For case group: Patients who come to Afyonkarahisar Health Sciences University Hospital Rheumatology Outpatient Clinic for treatment will constitute the case group of the study. For control group: Healthy individuals working in Afyonkarahisar Health Sciences University will constitute the control group of the study.

You may qualify if:

• For the case group
• Having been diagnosed with any rheumatic disease (rheumatoid arthritis, ankylosing spondylitis… etc.) by a rheumatologist.
• Not having any acute (fracture, surgery, etc.) or chronic disease (cognitive, neurological, etc.) other than rheumatic disease
• Being in the age range of 18-65.
• Presence of chronic pain for at least 3 months
• Pain over 3.4 cm according to the Visual Analogue Scale (having moderate pain).
• Standardized Mini Mental Test score\> 24
• At least primary education or literacy
• For control group:
• Absence of any known acute (fracture, surgery, etc.) or chronic disease (cognitive, neurological, etc.)
• Being in the age range of 18-65
• Standardized Mini Mental Test score\> 24
• Having at least primary education or literacy

You may not qualify if:

• Both control and case groups
• The presence of any problems (physical, cognitive or psychological) that will prevent the evaluations to be applied within the scope of the research
• Being pregnant

Sponsors & Collaborators

• Afyonkarahisar Health Sciences University: lead

Study Sites (1)

Afyonkarahisar Health Science University

Afyonkarahisar, 03030, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Rheumatic Diseases

Condition Hierarchy (Ancestors)

Musculoskeletal Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases

Study Officials

• EMEL TAŞVURAN HORATA

  Afyonkarahisar Health Science University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PhD; Assistant Professor

Study Record Dates

• First Submitted: January 14, 2021
• First Posted: January 22, 2021
• Study Start: November 1, 2020
• Primary Completion: January 1, 2022
• Study Completion: January 1, 2022
• Last Updated: January 20, 2022

Record last verified: 2022-01

Locations

TU (1)